Fifth Third Bancorp
CABA icon

Fifth Third Bancorp’s Cabaletta Bio CABA Stock Holding History

Fifth Third Bancorp’s Portfolio CABA Stock Details CABA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-13,928
Closed -$151K – 2347
2020
Q3 		$151K Hold
13,928
– – ﹤0.01% 974
2020
Q2 		$155K Buy
+13,928
New +$107K ﹤0.01% 950

Other funds holding CABA

5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Fifth Third Bancorp's CABA Position: Q4 2020 in Review

Fifth Third Bancorp sold out of Cabaletta Bio (CABA) in Q4 2020, closing a stake of 13,928 shares — an estimated $151K sold.

Fifth Third Bancorp first reported a position in CABA in Q2 2020 and held it in 2 quarters. The position peaked at $155K in Q2 2020. 55 funds tracked by Wall St. Rank hold CABA as of Q4 2020.

  • Fifth Third Bancorp reported no remaining Cabaletta Bio position as of Q4 2020 after selling out during the quarter.
  • Fifth Third Bancorp sold 13,928 Cabaletta Bio shares in Q4 2020, an estimated $151K.
  • Fifth Third Bancorp first reported a position in Cabaletta Bio in Q2 2020 and held it in 2 quarters.
  • Fifth Third Bancorp's Cabaletta Bio position peaked at $155K in Q2 2020.
  • 55 funds tracked by Wall St. Rank held Cabaletta Bio as of Q4 2020.

Based on Fifth Third Bancorp's 13F filing for Q4 2020, filed 16 Feb 2021.